Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. XENE
3. HUBS
4. NUE
5. ONON
6. AAPL
7. RTB
8. AZN
9. SPCX
10. TRMD

Go back to Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
(NASDAQ: ALLR) Delayed: 1.21 +0.05 (4.31%)
Previous Close $1.16    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.22    P/E N/A 
Day Low $1.11    EPS $ 
Volume 186,439       

(NASDAQ: ALLR) Delayed: 1.21 +0.05 (4.31%)
Previous Close $1.16    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.22    P/E N/A 
Day Low $1.11    EPS $ 
Volume 186,439